Johnson & Johnson Medical Korea Limited
The Director, Physical AI for Autonomous Discovery leads the In Silico Drug Discovery team at Johnson & Johnson, defining the Physical AI strategy and developing models for autonomous laboratory experimentation. This role combines AI, robotics, and scientific reasoning to create systems that perceive, reason, act, and continuously improve experimental outcomes. The position requires strong leadership, technical expertise in AI and machine learning, and the ability to collaborate across multidisciplinary teams to deploy reliable closed-loop learning in real laboratory environments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Johnson & Johnson Medical Korea Limited.
7% above the average for this role